206 related articles for article (PubMed ID: 12540963)
1. Platelet phosphatidylserine exposure and procoagulant activity in clotting whole blood--different effects of collagen, TRAP and calcium ionophore A23187.
Ramström S; Rånby M; Lindahl TL
Thromb Haemost; 2003 Jan; 89(1):132-41. PubMed ID: 12540963
[TBL] [Abstract][Full Text] [Related]
2. Persistence of procoagulant surface expression on activated human platelets: involvement of apoptosis and aminophospholipid translocase activity.
Leung R; Gwozdz AM; Wang H; Bang KW; Packham MA; Freedman J; Rand ML
J Thromb Haemost; 2007 Mar; 5(3):560-70. PubMed ID: 17155950
[TBL] [Abstract][Full Text] [Related]
3. Effects of platelets activated by different agonists on fibrin formation and thrombin generation.
Muravlev IA; Dobrovolsky AB; Antonova OA; Khaspekova SG; Mazurov AV
Platelets; 2023 Dec; 34(1):2139365. PubMed ID: 36325627
[TBL] [Abstract][Full Text] [Related]
4. Collagen but not fibrinogen surfaces induce bleb formation, exposure of phosphatidylserine, and procoagulant activity of adherent platelets: evidence for regulation by protein tyrosine kinase-dependent Ca2+ responses.
Heemskerk JW; Vuist WM; Feijge MA; Reutelingsperger CP; Lindhout T
Blood; 1997 Oct; 90(7):2615-25. PubMed ID: 9326228
[TBL] [Abstract][Full Text] [Related]
5. Merocyanine 540 as a fluorescent probe of altered membrane phospholipid asymmetry in activated whole blood platelets.
Watala C; Waczulikova I; Wieclawska B; Rozalski M; Gresner P; Gwoździński K; Mateasik A; Sikurova L
Cytometry; 2002 Nov; 49(3):119-33. PubMed ID: 12442312
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine enhances platelet procoagulant activity.
Tomasiak M; Rusak T; Gacko M; Stelmach H
Nephrol Dial Transplant; 2007 Jun; 22(6):1750-6. PubMed ID: 17308321
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural detection of surface exposed phosphatidylserine on activated blood platelets.
Stuart MC; Bevers EM; Comfurius P; Zwaal RF; Reutelingsperger CP; Frederik PM
Thromb Haemost; 1995 Oct; 74(4):1145-51. PubMed ID: 8560427
[TBL] [Abstract][Full Text] [Related]
8. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib.
Connor DE; Exner T; Ma DD; Joseph JE
Thromb Haemost; 2010 May; 103(5):1044-52. PubMed ID: 20390225
[TBL] [Abstract][Full Text] [Related]
9. Coagulation factors bound to procoagulant platelets concentrate in cap structures to promote clotting.
Podoplelova NA; Sveshnikova AN; Kotova YN; Eckly A; Receveur N; Nechipurenko DY; Obydennyi SI; Kireev II; Gachet C; Ataullakhanov FI; Mangin PH; Panteleev MA
Blood; 2016 Sep; 128(13):1745-55. PubMed ID: 27432876
[TBL] [Abstract][Full Text] [Related]
10. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.
Sinauridze EI; Kireev DA; Popenko NY; Pichugin AV; Panteleev MA; Krymskaya OV; Ataullakhanov FI
Thromb Haemost; 2007 Mar; 97(3):425-34. PubMed ID: 17334510
[TBL] [Abstract][Full Text] [Related]
11. Calpain inhibition by calpeptin does not prevent APLT activity reduction in PS-exposing platelets, but calpeptin has independent pro-apoptotic effects.
Gwozdz AM; Leung R; Wang H; Bang KW; Packham MA; Freedman J; Rand ML
Thromb Haemost; 2010 Jun; 103(6):1218-27. PubMed ID: 20352156
[TBL] [Abstract][Full Text] [Related]
12. Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet-mediated events during thrombus formation.
Rand ML; Wang H; Pluthero FG; Stafford AR; Ni R; Vaezzadeh N; Allison AC; Kahr WH; Weitz JI; Gross PL
J Thromb Haemost; 2012 Jun; 10(6):1109-19. PubMed ID: 22463102
[TBL] [Abstract][Full Text] [Related]
13. Concurrent and separate inside-out transition of platelet apoptosis and activation markers to the platelet surface.
Mutlu A; Gyulkhandanyan AV; Freedman J; Leytin V
Br J Haematol; 2013 Nov; 163(3):377-84. PubMed ID: 24033315
[TBL] [Abstract][Full Text] [Related]
14. Activated scramblase and inhibited aminophospholipid translocase cause phosphatidylserine exposure in a distinct platelet fraction.
Wolfs JL; Comfurius P; Rasmussen JT; Keuren JF; Lindhout T; Zwaal RF; Bevers EM
Cell Mol Life Sci; 2005 Jul; 62(13):1514-25. PubMed ID: 15971000
[TBL] [Abstract][Full Text] [Related]
15. Activation of the alternative pathway of complement by calcium-loaded erythrocytes resulting from loss of membrane phospholipid asymmetry.
Test ST; Mitsuyoshi J
J Lab Clin Med; 1997 Aug; 130(2):169-82. PubMed ID: 9280144
[TBL] [Abstract][Full Text] [Related]
16. Maintaining flippase activity in procoagulant platelets is a novel approach to reducing thrombin generation.
Millington-Burgess SL; Harper MT
J Thromb Haemost; 2022 Apr; 20(4):989-995. PubMed ID: 35034417
[TBL] [Abstract][Full Text] [Related]
17. Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT.
Connor DE; Exner T; Ma DD; Joseph JE
Blood Coagul Fibrinolysis; 2009 Oct; 20(7):558-64. PubMed ID: 19593114
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the Na+/H+ exchanger in membrane phosphatidylserine exposure during human platelet activation.
Bucki R; Pastore JJ; Giraud F; Janmey PA; Sulpice JC
Biochim Biophys Acta; 2006 Feb; 1761(2):195-204. PubMed ID: 16459134
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of platelet aggregation and aminophospholipid exposure by calpain.
Bachelot-Loza C; Badol P; Brohard-Bohn B; Fraiz N; Cano E; Rendu F
Br J Haematol; 2006 May; 133(4):419-26. PubMed ID: 16643450
[TBL] [Abstract][Full Text] [Related]
20. Vitamin E inhibition on platelet procoagulant activity: involvement of aminophospholipid translocase activity.
Kim JE; Han M; Hanl KS; Kim HK
Thromb Res; 2011 May; 127(5):435-42. PubMed ID: 21296386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]